Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIIi concentrate
Rouzioux, C.; Chamaret, S.; Montagnier, L.; Carnelli, V.; Rolland, G.; Mannucci, P.M.
Lancet 1(8423): 271-272
1985
ISSN/ISBN: 0140-6736 PMID: 2857333 DOI: 10.1016/s0140-6736(85)91043-8Document Number: 420235
Document emailed within 0-6 h
Related Documents
Kolho, E.; Ebeling, F.; Rasi, V. 1992: Risk of HCV infection in haemophiliacs treated with a dry-heated factor VIII concentrate Thrombosis and Haemostasis 67(6): 728Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Mauser-Bunschoten, E.P.; Damen, M.; Reesink, H.W.; Roosendaal, G.; Chamuleau, R.A.; van den Berg, H.M. 1996: Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C Annals of Internal Medicine 125(4): 297-299
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Kessler, C.; Lusher, J.; Pierce, G.F.; Pierce, B.; Koerper, M.A.; Dickinson, J.C. 1995: Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIIi concentrate Lancet 346(8985): 1297-1298
Arrighi, S.; Rossi, R.; Borri, M.G.; Lesnikov, V.; Lesnikova, M.; Franco, E.; Divizia, M.; De Santis, M.E.; Bucci, E. 1995: "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate Thrombosis and Haemostasis 74(3): 868-873
Canales Albendea, M.A.; Villar Camacho, A.; Chamarro Merino, G.; Magallón Martínez, M. 1998: Ultrapure factor VIIi concentrate with double virus inactivation: study of pharmacokinetics in von Willebrand's disease patients Sangre 43(1): 93-94
Mannucci, P.M.; Zanetti, A.R.; Colombo, M.; Chistolini, A.; De Biasi, R.; Musso, R.; Tamponi, G. 1990: Antibody to hepatitis C virus after a vapour-heated factor VIIi concentrate. the Study Group of the Fondazione dell'Emofilia Thrombosis and Haemostasis 64(2): 232-234
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Richard, C.; Sedano, C.; Cuadrado, M.A.; Iriondo, A.; Bello, C.; Gandarillas, M.A.; Zubizarreta, A. 1986: Effect of a thymic factor on the concentration of a factor VIIi inhibitor in a patient with treated Hodgkin's disease Thrombosis and Haemostasis 55(2): 299-300
Smith, M.P.; Rice, K.M.; Savidge, G.F. 1997: Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment Thrombosis and Haemostasis 77(2): 406-407
Gatti, L.; Mannucci, P.M. 1984: Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies Thrombosis and Haemostasis 51(3): 379-384
Tham, C.J.; Trew, M.; Brager, N. 1999: Abnormal clotting and production of factor VIIi inhibitor in a patient treated with venlafaxine Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(9): 923-924
Andes, W.A. 1983: Factor VIIi concentrate--hepatitis JAMA 249(17): 2331
Komuro, K.; Okuyama, K.; Fukushima, Y. 1988: Non-A, non-B hepatitis virus and heat-treated blood products Nihon Rinsho. Japanese Journal of Clinical Medicine 46(12): 2744-2749
Mauser-Bunschoten, E.P.; Roosendaal, G.; Bruin, M.; van Dijken, P.J. 1990: Disappearance of factor VIIi antibodies upon frequent administration of factor VIIi Folia Haematologica 117(4): 533-537
Allain, J.P.; Steinbuch, M.; Meunier, L.; Muller, J.Y.; Soulier, J.P. 1976: Substitutive treatment of hemopjolia a using a new factor VIIi concentrate La Nouvelle Presse Medicale 5(16): 1047-1050